KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $12.37 $15.59 Friday, 26th Apr 2024 URGN stock ended at $14.15. This is 2.39% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 4.60% from a day low at $13.69 to a day high of $14.32.
90 days $12.37 $19.87
52 weeks $8.69 $24.13

Historical UroGen Pharma Ltd prices

Date Open High Low Close Volume
Dec 01, 2023 $13.25 $13.25 $12.76 $13.03 226 851
Nov 30, 2023 $12.97 $13.78 $12.97 $13.19 239 232
Nov 29, 2023 $13.13 $13.45 $12.80 $12.84 147 314
Nov 28, 2023 $12.81 $13.07 $12.42 $13.00 144 401
Nov 27, 2023 $12.93 $13.04 $12.17 $12.78 308 768
Nov 24, 2023 $12.61 $13.22 $12.61 $12.95 142 793
Nov 22, 2023 $12.80 $12.99 $12.30 $12.53 266 481
Nov 21, 2023 $12.29 $12.86 $12.25 $12.67 224 489
Nov 20, 2023 $12.60 $13.21 $12.20 $12.43 400 563
Nov 17, 2023 $12.20 $12.70 $12.06 $12.46 288 321
Nov 16, 2023 $11.58 $12.03 $11.57 $11.99 253 263
Nov 15, 2023 $11.55 $11.74 $10.92 $11.58 366 315
Nov 14, 2023 $12.17 $12.17 $11.17 $11.68 322 289
Nov 13, 2023 $11.48 $11.80 $11.31 $11.76 289 180
Nov 10, 2023 $11.41 $11.59 $11.20 $11.46 205 967
Nov 09, 2023 $11.75 $11.76 $11.39 $11.47 343 249
Nov 08, 2023 $11.75 $12.13 $11.39 $11.57 642 001
Nov 07, 2023 $11.35 $11.88 $11.27 $11.63 216 116
Nov 06, 2023 $11.60 $11.64 $11.33 $11.41 123 695
Nov 03, 2023 $11.68 $12.00 $11.52 $11.57 216 802
Nov 02, 2023 $11.36 $11.61 $11.06 $11.47 115 421
Nov 01, 2023 $11.14 $11.38 $10.92 $11.36 103 074
Oct 31, 2023 $10.85 $11.37 $10.85 $11.21 171 618
Oct 30, 2023 $11.18 $11.21 $10.63 $10.87 129 759
Oct 27, 2023 $11.13 $11.27 $10.94 $11.06 137 467
Click to get the best stock tips daily for free!

About UroGen Pharma Ltd

UroGen Pharma Ltd UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead product candidate is UGN-102, which is in Phase III clinical trials for the treatment of several forms... URGN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT